Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Similarities and Differences Between Carotid Artery and Coronary Artery Function.

Peace A, Van Mil A, Jones H, Thijssen DHJ.

Curr Cardiol Rev. 2018;14(4):254-263. doi: 10.2174/1573403X14666180910125638. Review.

PMID:
30198437
2.

Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls, and potential.

van Mil A, Balk GM, Neef K, Buikema JW, Asselbergs FW, Wu SM, Doevendans PA, Sluijter JPG.

Cardiovasc Res. 2018 Dec 1;114(14):1828-1842. doi: 10.1093/cvr/cvy208.

PMID:
30169602
3.

High Growth Rate of Pancreatic Ductal Adenocarcinoma in CDKN2A-p16-Leiden Mutation Carriers.

Ibrahim IS, Wasser MN, Wu Y, Inderson A, de Vos Tot Nederveen Cappel WH, Morreau H, Hes FJ, Veenendaal RA, Putter H, Feshtali S, van Mil AM, Gruis NA, Tollenaar RA, Bergman W, Bonsing BA, Vasen HFA.

Cancer Prev Res (Phila). 2018 Sep;11(9):551-556. doi: 10.1158/1940-6207.CAPR-18-0035. Epub 2018 Jul 10.

PMID:
29991580
4.

Lack of evidence for a causal role of CALR3 in monogenic cardiomyopathy.

Verhagen JMA, Veldman JH, van der Zwaag PA, von der Thüsen JH, Brosens E, Christiaans I, Dooijes D, Helderman-van den Enden ATJM, Lekanne Deprez RH, Michels M, van Mil AM, Oldenburg RA, van der Smagt JJ, van den Wijngaard A, Wessels MW, Hofstra RMW, van Slegtenhorst MA, Jongbloed JDH, van de Laar IMBH.

Eur J Hum Genet. 2018 Nov;26(11):1603-1610. doi: 10.1038/s41431-018-0208-1. Epub 2018 Jul 9.

5.

MMISH: Multicolor microRNA in situ hybridization for paraffin embedded samples.

Lei Z, van Mil A, Xiao J, Metz CHG, van Eeuwijk ECM, Doevendans PA, Sluijter JPG.

Biotechnol Rep (Amst). 2018 May 1;18:e00255. doi: 10.1016/j.btre.2018.e00255. eCollection 2018 Jun.

6.

Engineering a 3D-Bioprinted Model of Human Heart Valve Disease Using Nanoindentation-Based Biomechanics.

van der Valk DC, van der Ven CFT, Blaser MC, Grolman JM, Wu PJ, Fenton OS, Lee LH, Tibbitt MW, Andresen JL, Wen JR, Ha AH, Buffolo F, van Mil A, Bouten CVC, Body SC, Mooney DJ, Sluijter JPG, Aikawa M, Hjortnaes J, Langer R, Aikawa E.

Nanomaterials (Basel). 2018 May 3;8(5). pii: E296. doi: 10.3390/nano8050296.

7.

Similarity between carotid and coronary artery responses to sympathetic stimulation and the role of α1-receptors in humans.

van Mil ACCM, Tymko MM, Kerstens TP, Stembridge M, Green DJ, Ainslie PN, Thijssen DHJ.

J Appl Physiol (1985). 2018 Aug 1;125(2):409-418. doi: 10.1152/japplphysiol.00386.2017. Epub 2018 Mar 22.

PMID:
29565771
8.

Carotid Artery Reactivity Predicts Events in Peripheral Arterial Disease Patients.

van Mil ACCM, Pouwels S, Wilbrink J, Warlé MC, Thijssen DHJ.

Ann Surg. 2019 Apr;269(4):767-773. doi: 10.1097/SLA.0000000000002558.

PMID:
29064890
9.

A Dutch MYH7 founder mutation, p.(Asn1918Lys), is associated with early onset cardiomyopathy and congenital heart defects.

van der Linde IHM, Hiemstra YL, Bökenkamp R, van Mil AM, Breuning MH, Ruivenkamp C, Ten Broeke SW, Veldkamp RF, van Waning JI, van Slegtenhorst MA, van Spaendonck-Zwarts KY, Lekanne Deprez RH, Herkert JC, Boven L, van der Zwaag PA, Jongbloed JDH, Bootsma M, Barge-Schaapveld DQCM.

Neth Heart J. 2017 Dec;25(12):675-681. doi: 10.1007/s12471-017-1037-5. Epub 2017 Sep 1.

10.

Pharmacodynamics of Cefepime Combined with Tazobactam against Clinically Relevant Enterobacteriaceae in a Neutropenic Mouse Thigh Model.

Melchers MJ, van Mil AC, Lagarde C, den Hartigh J, Mouton JW.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00267-17. doi: 10.1128/AAC.00267-17. Print 2017 Sep.

11.

Impact of lifelong exercise training on endothelial ischemia-reperfusion and ischemic preconditioning in humans.

Maessen MFH, van Mil ACCM, Straathof Y, Riksen NP, Rongen GAPJM, Hopman MTE, Eijsvogels TMH, Thijssen DHJ.

Am J Physiol Regul Integr Comp Physiol. 2017 May 1;312(5):R828-R834. doi: 10.1152/ajpregu.00466.2016. Epub 2017 Mar 15.

12.

Correlation of carotid artery reactivity with cardiovascular risk factors and coronary artery vasodilator responses in asymptomatic, healthy volunteers.

van Mil AC, Hartman Y, van Oorschot F, Heemels A, Bax N, Dawson EA, Hopkins N, Hopman MT, Green DJ, Oxborough DL, Thijssen DH.

J Hypertens. 2017 May;35(5):1026-1034. doi: 10.1097/HJH.0000000000001274.

PMID:
28129249
13.

In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease.

van der Ven CF, Wu PJ, Tibbitt MW, van Mil A, Sluijter JP, Langer R, Aikawa E.

Clin Sci (Lond). 2017 Feb 1;131(3):181-195. doi: 10.1042/CS20160378. Review.

14.

Pharmacodynamics of Ceftolozane Combined with Tazobactam against Enterobacteriaceae in a Neutropenic Mouse Thigh Model.

Melchers MJ, Mavridou E, van Mil AC, Lagarde C, Mouton JW.

Antimicrob Agents Chemother. 2016 Nov 21;60(12):7272-7279. Print 2016 Dec.

15.

Impact of volunteer-related and methodology-related factors on the reproducibility of brachial artery flow-mediated vasodilation: analysis of 672 individual repeated measurements.

van Mil AC, Greyling A, Zock PL, Geleijnse JM, Hopman MT, Mensink RP, Reesink KD, Green DJ, Ghiadoni L, Thijssen DH.

J Hypertens. 2016 Sep;34(9):1738-45. doi: 10.1097/HJH.0000000000001012.

PMID:
27488550
16.

Reply to: "Adherence to guidelines strongly improves reproducibility of brachial artery flow-mediated dilation. Common mistakes and methodological issue".

Greyling A, van Mil ACCM, Zock PL, Green DJ, Ghiadoni L, Thijssen DH; TIFN International Working Group on Flow Mediated Dilation.

Atherosclerosis. 2016 Aug;251:492. doi: 10.1016/j.atherosclerosis.2016.06.017. Epub 2016 Jun 10. No abstract available.

PMID:
27316634
17.

Assessing the perceived quality of brachial artery Flow Mediated Dilation studies for inclusion in meta-analyses and systematic reviews: Description of data employed in the development of a scoring ;tool based on currently accepted guidelines.

Greyling A, van Mil AC, Zock PL, Green DJ, Ghiadoni L, Thijssen DH; TIFN International Working Group on Flow Mediated Dilation.

Data Brief. 2016 May 13;8:73-7. doi: 10.1016/j.dib.2016.05.011. eCollection 2016 Sep.

18.

Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.

Vasen H, Ibrahim I, Ponce CG, Slater EP, Matthäi E, Carrato A, Earl J, Robbers K, van Mil AM, Potjer T, Bonsing BA, de Vos Tot Nederveen Cappel WH, Bergman W, Wasser M, Morreau H, Klöppel G, Schicker C, Steinkamp M, Figiel J, Esposito I, Mocci E, Vazquez-Sequeiros E, Sanjuanbenito A, Muñoz-Beltran M, Montans J, Langer P, Fendrich V, Bartsch DK.

J Clin Oncol. 2016 Jun 10;34(17):2010-9. doi: 10.1200/JCO.2015.64.0730. Epub 2016 Apr 25.

PMID:
27114589
19.

Adherence to guidelines strongly improves reproducibility of brachial artery flow-mediated dilation.

Greyling A, van Mil AC, Zock PL, Green DJ, Ghiadoni L, Thijssen DH; TIFN International Working Group on Flow Mediated Dilation.

Atherosclerosis. 2016 May;248:196-202. doi: 10.1016/j.atherosclerosis.2016.03.011. Epub 2016 Mar 11. Review.

20.

MicroRNA 214 Is a Potential Regulator of Thyroid Hormone Levels in the Mouse Heart Following Myocardial Infarction, by Targeting the Thyroid-Hormone-Inactivating Enzyme Deiodinase Type III.

Janssen R, Zuidwijk MJ, Muller A, van Mil A, Dirkx E, Oudejans CB, Paulus WJ, Simonides WS.

Front Endocrinol (Lausanne). 2016 Mar 9;7:22. doi: 10.3389/fendo.2016.00022. eCollection 2016.

21.

Interaction between left ventricular twist mechanics and arterial haemodynamics during localised, non-metabolic hyperaemia with and without blood flow restriction.

van Mil AC, Pearson J, Drane AL, Cockcroft JR, McDonnell BJ, Stöhr EJ.

Exp Physiol. 2016 Apr;101(4):509-20. doi: 10.1113/EP085623. Epub 2016 Mar 2.

22.

Pharmacodynamics of Ceftazidime and Avibactam in Neutropenic Mice with Thigh or Lung Infection.

Berkhout J, Melchers MJ, van Mil AC, Seyedmousavi S, Lagarde CM, Schuck VJ, Nichols WW, Mouton JW.

Antimicrob Agents Chemother. 2015 Nov 2;60(1):368-75. doi: 10.1128/AAC.01269-15. Print 2016 Jan.

23.

In Vitro Activity of Ceftolozane Alone and in Combination with Tazobactam against Extended-Spectrum-β-Lactamase-Harboring Enterobacteriaceae.

Melchers MJ, van Mil AC, Mouton JW.

Antimicrob Agents Chemother. 2015 Aug;59(8):4521-5. doi: 10.1128/AAC.04498-14. Epub 2015 May 18.

24.

MicroRNA-132/212 family enhances arteriogenesis after hindlimb ischaemia through modulation of the Ras-MAPK pathway.

Lei Z, van Mil A, Brandt MM, Grundmann S, Hoefer I, Smits M, El Azzouzi H, Fukao T, Cheng C, Doevendans PA, Sluijter JP.

J Cell Mol Med. 2015 Aug;19(8):1994-2005. doi: 10.1111/jcmm.12586. Epub 2015 May 6.

25.

Plasma and epithelial lining fluid pharmacokinetics of ceftolozane and tazobactam alone and in combination in mice.

Melchers MJ, Mavridou E, Seyedmousavi S, van Mil AC, Lagarde C, Mouton JW.

Antimicrob Agents Chemother. 2015;59(6):3373-6. doi: 10.1128/AAC.04402-14. Epub 2015 Mar 30.

26.

MicroRNA Therapeutics for Cardiac Regeneration.

Lei Z, Sluijter JP, van Mil A.

Mini Rev Med Chem. 2015;15(6):441-51. Review.

PMID:
25807943
27.

A survey of substance use for cognitive enhancement by university students in the Netherlands.

Schelle KJ, Olthof BM, Reintjes W, Bundt C, Gusman-Vermeer J, van Mil AC.

Front Syst Neurosci. 2015 Feb 17;9:10. doi: 10.3389/fnsys.2015.00010. eCollection 2015.

28.

Pharmacokinetics and penetration of ceftazidime and avibactam into epithelial lining fluid in thigh- and lung-infected mice.

Berkhout J, Melchers MJ, van Mil AC, Seyedmousavi S, Lagarde CM, Nichols WW, Mouton JW.

Antimicrob Agents Chemother. 2015 Apr;59(4):2299-304. doi: 10.1128/AAC.04627-14. Epub 2015 Feb 2.

29.

In vitro activity of ceftazidime-avibactam combination in in vitro checkerboard assays.

Berkhout J, Melchers MJ, van Mil AC, Nichols WW, Mouton JW.

Antimicrob Agents Chemother. 2015 Feb;59(2):1138-44. doi: 10.1128/AAC.04146-14. Epub 2014 Dec 8.

30.

Pharmacodynamics of imipenem in combination with β-lactamase inhibitor MK7655 in a murine thigh model.

Mavridou E, Melchers RJ, van Mil AC, Mangin E, Motyl MR, Mouton JW.

Antimicrob Agents Chemother. 2015 Feb;59(2):790-5. doi: 10.1128/AAC.03706-14. Epub 2014 Nov 17.

31.

Functional assessment of potential splice site variants in arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Groeneweg JA, Ummels A, Mulder M, Bikker H, van der Smagt JJ, van Mil AM, Homfray T, Post JG, Elvan A, van der Heijden JF, Houweling AC, Jongbloed JD, Wilde AA, van Tintelen JP, Hauer RN, Dooijes D.

Heart Rhythm. 2014 Nov;11(11):2010-7. doi: 10.1016/j.hrthm.2014.07.041. Epub 2014 Jul 31.

PMID:
25087486
32.

PDZ domain-binding motif regulates cardiomyocyte compartment-specific NaV1.5 channel expression and function.

Shy D, Gillet L, Ogrodnik J, Albesa M, Verkerk AO, Wolswinkel R, Rougier JS, Barc J, Essers MC, Syam N, Marsman RF, van Mil AM, Rotman S, Redon R, Bezzina CR, Remme CA, Abriel H.

Circulation. 2014 Jul 8;130(2):147-60. doi: 10.1161/CIRCULATIONAHA.113.007852. Epub 2014 Jun 3.

PMID:
24895455
33.

Inhibition of miR-25 improves cardiac contractility in the failing heart.

Wahlquist C, Jeong D, Rojas-Muñoz A, Kho C, Lee A, Mitsuyama S, van Mil A, Park WJ, Sluijter JP, Doevendans PA, Hajjar RJ, Mercola M.

Nature. 2014 Apr 24;508(7497):531-5. doi: 10.1038/nature13073. Epub 2014 Mar 12.

34.

Post-transcriptional regulation of α-1-antichymotrypsin by microRNA-137 in chronic heart failure and mechanical support.

Lok SI, van Mil A, Bovenschen N, van der Weide P, van Kuik J, van Wichen D, Peeters T, Siera E, Winkens B, Sluijter JP, Doevendans PA, da Costa Martins PA, de Jonge N, de Weger RA.

Circ Heart Fail. 2013 Jul;6(4):853-61. doi: 10.1161/CIRCHEARTFAILURE.112.000255. Epub 2013 May 2.

PMID:
23640964
35.

MicroRNA-1 enhances the angiogenic differentiation of human cardiomyocyte progenitor cells.

van Mil A, Vrijsen KR, Goumans MJ, Metz CH, Doevendans PA, Sluijter JP.

J Mol Med (Berl). 2013 Aug;91(8):1001-12. doi: 10.1007/s00109-013-1017-1. Epub 2013 Apr 27.

PMID:
23625462
36.

Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy: overview of 10 years' experience.

van Spaendonck-Zwarts KY, van Rijsingen IA, van den Berg MP, Lekanne Deprez RH, Post JG, van Mil AM, Asselbergs FW, Christiaans I, van Langen IM, Wilde AA, de Boer RA, Jongbloed JD, Pinto YM, van Tintelen JP.

Eur J Heart Fail. 2013 Jun;15(6):628-36. doi: 10.1093/eurjhf/hft013. Epub 2013 Jan 24.

37.

Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs.

Oerlemans MI, Mosterd A, Dekker MS, de Vrey EA, van Mil A, Pasterkamp G, Doevendans PA, Hoes AW, Sluijter JP.

EMBO Mol Med. 2012 Nov;4(11):1176-85. doi: 10.1002/emmm.201201749. Epub 2012 Oct 1.

38.

Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers.

Yiu KH, Atsma DE, Delgado V, Ng AC, Witkowski TG, Ewe SH, Auger D, Holman ER, van Mil AM, Breuning MH, Tse HF, Bax JJ, Schalij MJ, Marsan NA.

PLoS One. 2012;7(5):e36115. doi: 10.1371/journal.pone.0036115. Epub 2012 May 4.

39.

MiR-155 inhibits cell migration of human cardiomyocyte progenitor cells (hCMPCs) via targeting of MMP-16.

Liu J, van Mil A, Aguor EN, Siddiqi S, Vrijsen K, Jaksani S, Metz C, Zhao J, Strijkers GJ, Doevendans PA, Sluijter JP.

J Cell Mol Med. 2012 Oct;16(10):2379-86. doi: 10.1111/j.1582-4934.2012.01551.x.

40.

MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release.

van Mil A, Grundmann S, Goumans MJ, Lei Z, Oerlemans MI, Jaksani S, Doevendans PA, Sluijter JP.

Cardiovasc Res. 2012 Mar 15;93(4):655-65. doi: 10.1093/cvr/cvs003. Epub 2012 Jan 6.

PMID:
22227154
41.

Letter by van Mil et al regarding, "Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells: role for miR-499".

van Mil A, Doevendans PA, Sluijter JP.

Circ Cardiovasc Genet. 2011 Feb;4(1):e3; author reply e4. doi: 10.1161/CIRCGENETICS.110.958595. No abstract available.

PMID:
21325154
42.

Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation.

Vasen HF, Wasser M, van Mil A, Tollenaar RA, Konstantinovski M, Gruis NA, Bergman W, Hes FJ, Hommes DW, Offerhaus GJ, Morreau H, Bonsing BA, de Vos tot Nederveen Cappel WH.

Gastroenterology. 2011 Mar;140(3):850-6. doi: 10.1053/j.gastro.2010.11.048. Epub 2010 Dec 1.

PMID:
21129377
43.

MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1.

Liu J, van Mil A, Vrijsen K, Zhao J, Gao L, Metz CH, Goumans MJ, Doevendans PA, Sluijter JP.

J Cell Mol Med. 2011 Jul;15(7):1474-82. doi: 10.1111/j.1582-4934.2010.01104.x. Epub 2010 Jun 9.

44.

MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells.

Sluijter JP, van Mil A, van Vliet P, Metz CH, Liu J, Doevendans PA, Goumans MJ.

Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):859-68. doi: 10.1161/ATVBAHA.109.197434. Epub 2010 Jan 15.

PMID:
20081117
45.

PTEN and TRP53 independently suppress Nanog expression in spermatogonial stem cells.

Kuijk EW, van Mil A, Brinkhof B, Penning LC, Colenbrander B, Roelen BA.

Stem Cells Dev. 2010 Jul;19(7):979-88. doi: 10.1089/scd.2009.0276.

PMID:
19845468
46.

The potential of modulating small RNA activity in vivo.

van Mil A, Doevendans PA, Sluijter JP.

Mini Rev Med Chem. 2009 Feb;9(2):235-48. Review.

PMID:
19200028
47.

Genetic testing in familial melanoma: uptake and implications.

de Snoo FA, Riedijk SR, van Mil AM, Bergman W, ter Huurne JA, Timman R, Bertina W, Gruis NA, Vasen HF, van Haeringen A, Breuning MH, Tibben A.

Psychooncology. 2008 Aug;17(8):790-6. doi: 10.1002/pon.1377.

PMID:
18613292
48.

Homozygosity for a CHEK2*1100delC mutation identified in familial colorectal cancer does not lead to a severe clinical phenotype.

van Puijenbroek M, van Asperen CJ, van Mil A, Devilee P, van Wezel T, Morreau H.

J Pathol. 2005 Jun;206(2):198-204.

PMID:
15818573
49.

Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance.

Hendriks YM, Wagner A, Morreau H, Menko F, Stormorken A, Quehenberger F, Sandkuijl L, Møller P, Genuardi M, Van Houwelingen H, Tops C, Van Puijenbroek M, Verkuijlen P, Kenter G, Van Mil A, Meijers-Heijboer H, Tan GB, Breuning MH, Fodde R, Wijnen JT, Bröcker-Vriends AH, Vasen H.

Gastroenterology. 2004 Jul;127(1):17-25.

PMID:
15236168
50.

Nitric oxide mediates hypoxia-induced cerebral vasodilation in humans.

Van Mil AH, Spilt A, Van Buchem MA, Bollen EL, Teppema L, Westendorp RG, Blauw GJ.

J Appl Physiol (1985). 2002 Mar;92(3):962-6.

Supplemental Content

Loading ...
Support Center